The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche
Open accessAbstract
Tumor cell metastasis is facilitated by "premetastatic niches" formed in destination organs by invading bone marrow-derived cells (BMDCs). Lysyl oxidase (LOX) is critical for premetastatic niche formation. LOX secreted by hypoxic breast tumor cells accumulates at premetastatic sites, crosslinks collagen IV in the basement membrane, and is essential for CD11b+ myeloid cell recruitment. CD11b+ cells adhere to crosslinked collagen IV and produce matrix metalloproteinase-2, which cleaves collagen, enhancing the invasion and recruitment of BMDCs and metastasizing tumor cells. LOX inhibition prevents CD11b+ cell recruitment and metastatic growth. CD11b+ cells and LOX also colocalize in biopsies of human metastases. Our findings demonstrate a critical role for LOX in premetastatic niche formation and support targeting LOX for the treatment and prevention of metastatic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Specifically, hypoxia-induced lysyl oxidase contributes to the pre-metastatic niche in a process that includes collagen crosslinking and recruitment of CD11b + myeloid cells (Erler et al., 2009).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Erler et al., 2009
In the citing paper
“The BMDCs promote metastasis by producing chemokines that recruit tumor cells to the lung by mechanisms that include stimulation of tumor cell extravasation”
From Hypoxic control of metastasis (2016) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
Self-citationRetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Jemal, A., Siegel, R. L., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,184
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,333
Tensional homeostasis and the malignant phenotype
Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A., Reinhart-King, C. A., Margulies, S. S., Dembo, M., Boettiger, D., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.010 · Cited by 3,941
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J. S., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,677
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662 · cited 1×
“Increased metastases, enhanced tumor progression, and decreased patient survival have been associated with primary tumors that contain large numbers of poorly oxygenated (hypoxic) tumor cells (Cairns et al., 2003; Hockel and Vaupel, 2001; Pouyssegur et al., 2006).”
Background
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 999
Selectins as Mediators of Lung Metastasis
Laubli, H. P., & Borsig, L. (2010) · Cancer Microenvironment · doi:10.1007/s12307-010-0043-6 · Cited by 85
Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis
Li, S., Pritchard, D. M., & Yu, L.-G. (2022) · Cancers · doi:10.3390/cancers14133263 · Cited by 82
Yan, H. H., Jiang, J. D., Pang, Y., Achyut, B. R., Lizardo, M. M., Liang, X., Hunter, K. W., Khanna, C., Hollander, C. M., & Li, Y. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-2282-t · Cited by 83
Xie, Y., Wang, X., Wang, W., Pu, N., & Liu, L. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06422-5 · Cited by 80
The Bone Extracellular Matrix as an Ideal Milieu for Cancer Cell Metastases
Kolb, A. D., & Bussard, K. M. (2019) · Cancers · doi:10.3390/cancers11071020 · Cited by 92
CD44v6 Coordinates Tumor Matrix-triggered Motility and Apoptosis Resistance
Jung, T., Groß, W., & Zöller, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.208421 · Cited by 80
Hypoxia promotes the invasion and metastasis of laryngeal cancer cells via EMT
Zuo, J., Wen, J., Lei, M., Wen, M., Li, S., Lv, X., Luo, Z., & Wen, G. (2016) · Medical Oncology · doi:10.1007/s12032-015-0716-6 · Cited by 78
Palamakumbura, A. H., Vora, S. R., Nugent, M. A., Kirsch, K. H., Sonenshein, G. E., & Trackman, P. C. (2009) · Oncogene · doi:10.1038/onc.2009.203 · Cited by 79
Artacho‐Cordón, F., Ríos‐Arrabal, S., Lara, P. C., Artacho-Cordón, A., Calvente, I., & Núñez, M. I. (2012) · Surgical Oncology · doi:10.1016/j.suronc.2012.06.001 · Cited by 81
Lysyl oxidase: A lung adenocarcinoma biomarker of invasion and survival
Wilgus, M., Borczuk, A., Stoopler, M. B., Ginsburg, M. E., Gorenstein, L. A., Sonett, J. R., & Powell, C. A. (2010) · Cancer · doi:10.1002/cncr.25768 · Cited by 78
Lysyl Oxidase Is a Strong Determinant of Tumor Cell Colonization in Bone
Reynaud, C., Ferreras, L., Mauro, P. D., Kan, C. W. S., Croset, M., Bonnelye, E., Pez, F., Thomas, C., Aimond, G., Karnoub, A. E., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2621 · Cited by 78
Yang, S. (2017) · Frontiers in bioscience · doi:10.2741/4641 · Cited by 77
Aguado, B. A., Caffe, J. R., Nanavati, D. M., Rao, S. S., Bushnell, G. G., Azarin, S. M., & Shea, L. D. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.01.043 · Cited by 81
Characteristics of pre-metastatic niche: the landscape of molecular and cellular pathways
Wang, H., Pan, J., Barsky, L., Jacob, J. C., Zheng, Y., Gao, C., Wang, S., Zhu, W., Sun, H., Lu, L., et al. (2021) · Molecular Biomedicine · doi:10.1186/s43556-020-00022-z · Cited by 81
Iwai, L. K., Payne, L. S., Luczynski, M. T., Chang, F., Xu, H., Clinton, R. W., Paul, A., Esposito, E. A., Gridley, S., Leitinger, B., et al. (2013) · Biochemical Journal · doi:10.1042/bj20121750 · Cited by 79
Hypoxia-driven immunosuppression contributes to the pre-metastatic niche
Sceneay, J., Parker, B. S., Smyth, M. J., & Möller, A. (2012) · OncoImmunology · doi:10.4161/onci.22355 · Cited by 80
Interplay Between LOX Enzymes and Integrins in the Tumor Microenvironment
Amendola, P. G., Reuten, R., & Erler, J. T. (2019) · Cancers · doi:10.3390/cancers11050729 · Cited by 76
Self-citationCancer-associated fibroblasts in digestive tumors
Huang, L., Xu, A., Liu, S., Liu, W., & Li, T.-J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17804 · Cited by 77
Molecular Mechanisms of Resistance to Tumour Anti-Angiogenic Strategies
Grépin, R., & Pagès, G. (2010) · Journal of Oncology · doi:10.1155/2010/835680 · Cited by 76
Calvé, B. L., Griveau, A., Vindrieux, D., Maréchal, R., Wiel, C., Svrcek, M., Gout, J., Martin, L. A., Payen, L. F., Cros, J. F., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8527 · Cited by 72
Fouani, L., Menezes, S. V., Paulson, M., Richardson, D. R., & Kovačević, Ž. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.001 · Cited by 74
Molecular Regulation of Bone Metastasis Pathogenesis
Wu, M., Li, C., Yiang, G., Cheng, Y., Tsai, A. P., Hou, Y.-T., Ho, Y.-C., Hou, M., & Chu, P. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000489184 · Cited by 76
Lorenzo-Sanz, L., & Muñoz, P. (2019) · Cancer Microenvironment · doi:10.1007/s12307-019-00232-2 · Cited by 76
Ge, Y., Mu, W., Ba, Q., Li, J., Jiang, Y., Xia, Q., & Wang, H. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.003 · Cited by 72
Turning the Oxygen Dial: Balancing the Highs and Lows
Baik, A. H., & Jain, I. H. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.04.005 · Cited by 70
Tumor-Associated Macrophages: Protumoral Macrophages in Inflammatory Tumor Microenvironment
Malekghasemi, S., Majidi, J., Baghbanzadeh, A., Abdolalizadeh, J., Baradaran, B., & Maleki, L. A. (2020) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2020.066 · Cited by 77
The role of hypoxia on prostate cancer progression and metastasis
Mohamed, O. A. A., Tesen, H. S., Hany, M., Sherif, A., Abdelwahab, M. M., & Elnaggar, M. H. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08251-5 · Cited by 81
The temporal progression of lung immune remodeling during breast cancer metastasis
McGinnis, C. S., Miao, Z., Superville, D. A., Yao, W., Goga, A., Reticker-Flynn, N. E., Winkler, J., & Satpathy, A. T. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.05.004 · Cited by 80
Joo, Y. N., Jin, H., Eun, S. Y., Park, S. W., Chang, K. C., & Kim, H. J. (2014) · Oncotarget · doi:10.18632/oncotarget.2427 · Cited by 74
One microenvironment does not fit all: heterogeneity beyond cancer cells
Kim, I. S., & Zhang, X. H.-F. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9643-z · Cited by 75
Varki, A. P., Varki, N. M., & Borsig, L. (2009) · New England Journal of Medicine · doi:10.1056/nejmc090143 · Cited by 74
Pericytes in the Premetastatic Niche
Paiva, A. E., Lousado, L., Guerra, D. A. P., de Azevedo, P. O., Sena, I. F. G., Andreotti, J. P., Santos, G. S. P., Gonçalves, R., Mintz, A., & Birbrair, A. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3883 · Cited by 73
Circulating Tumor Cell-Neutrophil Tango along the Metastatic Process
Saini, M., Szczerba, B. M., & Aceto, N. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1972 · Cited by 74
Mack, G. S., & Marshall, A. (2010) · Nature Biotechnology · doi:10.1038/nbt0310-214 · Cited by 73
Hypoxic Microenvironment and Metastatic Bone Disease
Hiraga, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113523 · Cited by 78
Molecular insights into tumour metastasis: tracing the dominant events
Jin, K., Li, T., van Dam, H., Zhou, F., & Zhang, L. (2016) · The Journal of Pathology · doi:10.1002/path.4871 · Cited by 73
LOXL1 Is Regulated by Integrin α11 and Promotes Non-Small Cell Lung Cancer Tumorigenicity
Zeltz, C., Pasko, E., Cox, T. R., Navab, R., & Tsao, M. (2019) · Cancers · doi:10.3390/cancers11050705 · Cited by 72
Self-citationT Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy
Haj-Shomaly, J., Vorontsova, A., Barenholz‐Cohen, T., Levi-Galibov, O., Devarasetty, M., Timaner, M., Raviv, Z., Cooper, T. J., Söker, S., Hasson, P., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1012 · Cited by 72
Weidenfeld, K., Schif‐Zuck, S., Abu-Tayeh, H., Kang, K., Kessler, O., Weissmann, M., Neufeld, G., & Barkan, D. (2016) · Oncotarget · doi:10.18632/oncotarget.12109 · Cited by 72
Xie, H.-Y., Shao, Z., & Li, D. (2017) · 癌症:英文版 · doi:10.1186/s40880-017-0202-y · Cited by 76
Network‐based drugs and biomarkers
Erler, J. T., & Linding, R. (2009) · The Journal of Pathology · doi:10.1002/path.2646 · Cited by 72
Self-citationLysyl oxidase promotes bleomycin-induced lung fibrosis through modulating inflammation
Cheng, T., Liu, Q., Zhang, R., Zhang, Y., Chen, J., Yu, R., & Ge, G. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mju039 · Cited by 74
Autophagy, a double-edged sword in anti-angiogenesis therapy
Liu, J., Fan, L., Wang, H., & Sun, G. (2015) · Medical Oncology · doi:10.1007/s12032-015-0721-9 · Cited by 72
Emerging therapeutic targets in metastatic progression: A focus on breast cancer
Li, Z., & Kang, Y. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.03.003 · Cited by 71
Epigenetic regulation of matrix metalloproteinases and their collagen substrates in cancer
Chernov, A. V., & Strongin, A. Y. (2011) · bmc · doi:10.1515/bmc.2011.017 · Cited by 69
Carpenter, R., Kwak, J., Peyton, S. R., & Lee, J. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0307-x · Cited by 69
Gui, J., Zahedi, F., Ortiz, A., Cho, C., Katlinski, K. V., Alicea-Torres, K. M., Li, J., Todd, L., Zhang, H., Beiting, D. P., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0064-0 · Cited by 70
Biomechanical Contributions to Macrophage Activation in the Tumor Microenvironment
Hoffmann, E. J., & Ponik, S. M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00787 · Cited by 68
Extracellular matrix genes as hypoxia-inducible targets
Myllyharju, J., & Schipani, E. (2009) · Cell and Tissue Research · doi:10.1007/s00441-009-0841-7 · Cited by 72
Regulation of Blood and Lymphatic Vessels by Immune Cells in Tumors and Metastasis
Mazzone, M., & Bergers, G. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114721 · Cited by 70
Myeloid cells in cancer-related inflammation
Caronni, N., Savino, B., & Bonecchi, R. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.10.001 · Cited by 71
Single-Cell Transcriptomics in Cancer Immunobiology: The Future of Precision Oncology
Valdés‐Mora, F., Handler, K., Law, A. M. K., Salomon, R., Oakes, S. R., Ormandy, C. J., & Gallego‐Ortega, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02582 · Cited by 69
Desmoplasia in Pancreatic Cancer. Can We Fight It?
Merika, E., Syrigos, K. N., & Saif, M. W. (2012) · Gastroenterology Research and Practice · doi:10.1155/2012/781765 · Cited by 68
Copper chaperone Atox1 plays role in breast cancer cell migration
Blockhuys, S., & Wittung-Stafshede, P. E. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.148 · Cited by 68
Talati, P. G., Gu, L., Ellsworth, E., Girondo, M. A., Trerotola, M., Hoang, D. T., Leiby, B. E., Dagvadorj, A., McCue, P. A., Lallas, C. D., et al. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.04.026 · Cited by 68
Zhang, Y., Davis, C., Ryan, J. C., Janney, C., & Peña, M. M. O. (2013) · Clinical & Experimental Metastasis · doi:10.1007/s10585-013-9591-8 · Cited by 68
Bendinelli, P., Maroni, P., Matteucci, E., Luzzati, A., Perrucchini, G. G., & Desiderio, M. A. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.03.002 · Cited by 66
Luger, D., Yang, Y.-A., Raviv, A., Weinberg, D., Banerjee, S., Lee, M.-J., Trepel, J. B., Yang, H. H., & Wakefield, L. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076115 · Cited by 65
Zhuyan, J., Chen, M., Zhu, T., Bao, X., Zhen, T., Xing, K., Wang, Q., & Zhu, S. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00453-9 · Cited by 69
Nilsson, M., Adamo, H. H., Bergh, A. R. J., & Bergström, S. H. (2016) · Scientific Reports · doi:10.1038/srep19608 · Cited by 66
Estrogen receptors in breast and bone: from virtue of remodeling to vileness of metastasis
Bado, I., Gugala, Z., Fuqua, S. A. W., & Zhang, X. (2017) · Oncogene · doi:10.1038/onc.2017.94 · Cited by 65
Palmieri, V., Lazaris, A., Mayer, T. Z., Petrillo, S. K., Alamri, H., Rada, M., Jarrouj, G., Park, W., Gao, Z., McDonald, P. P., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5449 · Cited by 64
Emerging roles of the tumor-associated stroma in promoting tumor metastasis
Horimoto, Y., Polanska, U. M., Takahashi, Y., & Orimo, A. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20631 · Cited by 65
Involvement of Mesenchymal Stem Cells in Cancer Progression and Metastases
Chang, A., Schwertschkow, A., Nolta, J. A., & Wu, J. (2015) · Current Cancer Drug Targets · doi:10.2174/1568009615666150126154151 · Cited by 64
Wang, Y., Mirza, S., Wu, S., Zeng, J., Shi, W., Band, H., Band, V., & Duan, B. (2018) · Oncotarget · doi:10.18632/oncotarget.25891 · Cited by 69
A Complex and Evolutive Character: Two Face Aspects of ECM in Tumor Progression
Sala, M., Ros, M., & Saltel, F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01620 · Cited by 67
Hypoxia, a key factor in the immune microenvironment
Hu, J., Li, X., Yang, L., & Li, H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113068 · Cited by 67
Guédez, L., Jensen-Taubman, S., Bourboulia, D., Kwityn, C., Wei, B., Caterina, J. J., & Stetler‐Stevenson, W. G. (2012) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182619c8e · Cited by 64
Addressing cellular heterogeneity in tumor and circulation for refined prognostication
Lim, S. B., Yeo, T., Lee, W. D., Bhagat, A. A. S., Tan, S. J., Tan, D. S. W., Lim, W., & Lim, C. T. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1907904116 · Cited by 62
Targeting Myeloid-Derived Suppressor Cells for Premetastatic Niche Disruption After Tumor Resection
Tang, F., Tie, Y., Hong, W., Wei, Y., Tu, C., & Wei, X. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-020-09371-z · Cited by 63
Chang, J., & Erler, J. T. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5915-6_3 · Cited by 67
Self-citationJensen, L. D., Cao, R., Hedlund, E., Söll, I., Lundberg, J. O., Hauptmann, G., Steffensen, J. F., & Cao, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907608106 · Cited by 63
Sadri, N., & Zhang, P. J. (2013) · Cancers · doi:10.3390/cancers5020320 · Cited by 65
Zhou, Y., Xiaohua, W., Lei, J., Ruoyun, T., Xiong, M., He, W., Li, F., Ping, W., & Junwei, Y. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00053.2010 · Cited by 62
Tissue engineering the cancer microenvironment—challenges and opportunities
Papalazarou, V., Salmerón‐Sánchez, M., & Machesky, L. M. (2018) · Biophysical Reviews · doi:10.1007/s12551-018-0466-8 · Cited by 61
Zhang, J., Wu, Y., Lin, Y.-H., Guo, S., Ning, P.-F., Zheng, Z., Wang, Y., & Zhao, Y. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i22.2381 · Cited by 62
Lysyl oxidases: Emerging biomarkers and therapeutic targets for various diseases
Yang, N., Cao, D., Yin, X., Zhou, H., & Mao, X. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110791 · Cited by 61
Arresten, a Collagen-Derived Angiogenesis Inhibitor, Suppresses Invasion of Squamous Cell Carcinoma
Aikio, M., Alahuhta, I., Nurmenniemi, S., Suojanen, J., Palovuori, R., Teppo, S., Sorsa, T. A., López-Otı́n, C., Pihlajaniemi, T. A., Salo, T. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051044 · Cited by 61
Chen, L. C., Tu, S., Huang, C. S., Chen, C. S., Ho, C., Lin, H. W., Lee, C., Chang, H., Chang, C. H., Wu, C.-H., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-1986-8 · Cited by 61
Paidi, S. K., Rizwan, A., Zheng, C., Cheng, M., Glunde, K., & Barman, I. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1862 · Cited by 61
CXCL12-γ in primary tumors drives breast cancer metastasis
Ray, P., Stacer, A. C., Fenner, J., Cavnar, S. P., Meguiar, K. F., Brown, M. E., Luker, G. D., & Luker, G. D. (2014) · Oncogene · doi:10.1038/onc.2014.157 · Cited by 66
Choi, S. K., Kim, H. S., Jin, T., & Moon, W. K. (2017) · Oncotarget · doi:10.18632/oncotarget.14450 · Cited by 60
Hypoxic pathobiology of breast cancer metastasis
Schito, L., & Rey, S. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.05.004 · Cited by 63
Prognosis and targeting of pre-metastatic niche
Zhou, Y., Han, M. Y., & Gao, J. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.06.037 · Cited by 62
Zhang, X., Walke, G. R., Horváth, I., Kumar, R., Blockhuys, S., Holgersson, S., Walton, P. H., & Wittung-Stafshede, P. E. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2206905119 · Cited by 62
Li, Y., Li, M., Su, K., Zong, S., Zhang, H., & Xiong, L. (2023) · Theranostics · doi:10.7150/thno.82700 · Cited by 61
Gandhi, S., & Chandna, S. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9669-x · Cited by 60
Zhou, M., Zuo, Q., Huang, Y., & Li, L. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.02.017 · Cited by 59
Ferroptosis in Cancer Progression
Zhang, R., Chen, J., Wang, S., Zhang, W., Zheng, Q., & Cai, R. (2023) · Cells · doi:10.3390/cells12141820 · Cited by 57
Chen, W. L. K., & Simmons, C. A. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.01.004 · Cited by 57
Fazilaty, H., Gardaneh, M., Bahrami, T., Salmaninejad, A., & Behnam, B. (2013) · Tumor Biology · doi:10.1007/s13277-013-0831-y · Cited by 57
Discoidin Domain Receptor 2 Signaling Networks and Therapy in Lung Cancer
Payne, L. S., & Huang, P. H. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000164 · Cited by 57
Stölzel, F., Hackmann, K., Kuithan, F., Mohr, B., Füssel, M., Oelschlägel, U., Thiede, C., Röllig, C., Platzbecker, U., Schetelig, J., et al. (2012) · Transplantation · doi:10.1097/tp.0b013e3182481113 · Cited by 57
Microenvironment in metastasis: roadblocks and supportive niches
Pein, M., & Óskarsson, T. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00145.2015 · Cited by 59
The influence of the pre-metastatic niche on breast cancer metastasis
Ursini‐Siegel, J., & Siegel, P. M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.009 · Cited by 58
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
Goddard, E. T., Fischer, J., & Schedin, P. S. (2016) · Journal of Visualized Experiments · doi:10.3791/54903 · Cited by 68
Umezaki, N., Nakagawa, S., Yamashita, Y., Kitano, Y., Arima, K., Miyata, T., Hiyoshi, Y., Okabe, H., Nitta, H., Hayashi, H., et al. (2019) · Cancer Science · doi:10.1111/cas.14010 · Cited by 58
Strieder‐Barboza, C., Baker, N. A., Flesher, C. G., Karmakar, M., Neeley, C. K., Polsinelli, D., Dimick, J. B., Finks, J. F., Ghaferi, A. A., Varban, O. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-56242-z · Cited by 58
The role of tumor microenvironment and exosomes in dormancy and relapse
Attaran, S., & Bissell, M. J. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.09.008 · Cited by 57
Bone Metastases and Health in Prostate Cancer: From Pathophysiology to Clinical Implications
Baldessari, C., Pipitone, S., Molinaro, E., Cerma, K., Fanelli, M., Nasso, C., Oltrecolli, M., Pirola, M., D’Agostino, E., Pugliese, G., et al. (2023) · Cancers · doi:10.3390/cancers15051518 · Cited by 65
Metadata
- Authors
- Erler, J. T., Bennewith, K. L., Cox, T. R., Lang, G., Bird, D., Koong, A., Le, Q.-T., & Giaccia, A. J.
- Affiliations
- Institute of Cancer Research (GB)
- BC Cancer Agency (CA)
- Stanford Medicine (US)
- Corresponding author
- Giaccia, Amato J.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 15
- Issue
- 1
- Pages
- 35-44
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC3050620
- OpenAlex
- W2159744630
- Cited by
- 1,231
- References
- 40
- Citations by year
- 2026: 38 · 2025: 45 · 2024: 61 · 2023: 66 · 2022: 62 · 2021: 82 · 2020: 78 · 2019: 96 · 2018: 80 · 2017: 71 · 2016: 90 · 2015: 72 · 2014: 74 · 2013: 87 · 2012: 72
- FWCI
- 37.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Cancer Research UK
- National Cancer Institute (P01CA067166, T32CA009151)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- lysyl oxidase, pre-metastatic niche, metastasis, bone marrow-derived cells, hypoxia, breast cancer, CD11b+ myeloid cells, basement membrane, MMP-2, collagen degradation, metastasis prevention
- MeSH terms
- Animals, Hypoxia, Basement Membrane, Bone Marrow Cells, Breast Neoplasms, Cell Differentiation, Cell Movement, Cell Separation, Enzyme Activation, Humans, Lung Neoplasms, Protein-Lysine 6-Oxidase, Mice, Nude, Neoplasm Metastasis, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Disease Progression, Matrix Metalloproteinase 2, Myeloid Cells, Xenograft Model Antitumor Assays, Collagen Type IV, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review